A phase 1, randomized, double‐blind, placebo‐controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects

A phase 1, randomized, double‐blind, placebo‐controlled study to evaluate the safety, tolerability, and pharmacokinetics of single and multiple doses of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adult subjects

Abstract Aim To assess safety, tolerability, and pharmacokinetics of lisdexamfetamine dimesylate in Japanese and Caucasian healthy adults. Methods A phase 1, double‐blind, randomized, placebo‐controlled, single‐ and multiple‐dose study in Japanese and Caucasian subjects. Subjects received lisdexamfe...

Full description

Bibliographic Details
Main Authors: James Ermer, Patrick Martin, Mary Corcoran, Yumiko Matsuo
Format: Article
Language:English
Published: Wiley 2020-03-01
Series:Neuropsychopharmacology Reports
Subjects:
attention‐deficit/hyperactivity disorder
d‐amphetamine
lisdexamfetamine dimesylate
pharmacokinetics
psychopharmacology: clinical
safety
Online Access:https://doi.org/10.1002/npr2.12082

Internet

https://doi.org/10.1002/npr2.12082

Similar Items